Mayu Watanabe
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Helicobacter pylori Eradication Therapy-induced Severe Hypoglycemia in a Hemodialysis Patient with Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer.
Journal: Frontiers in endocrinology
Published: January 16, 2026
Correction: Maternal circulating GPIHBP1 levels and neonatal outcomes in patients with gestational diabetes mellitus: a pilot study.
Journal: Frontiers in clinical diabetes and healthcare
Published: October 14, 2025
Maternal circulating GPIHBP1 levels and neonatal outcomes in patients with gestational diabetes mellitus: a pilot study.
Journal: Frontiers in clinical diabetes and healthcare
Published: August 08, 2025
Acute-onset type 1 diabetes in an older patient with severe hypothermia and diabetic ketoacidosis (pH 6.84) triggered by traumatic hemothorax.
Journal: Endocrinology, diabetes & metabolism case reports
Published: July 09, 2025
Perinatal and postpartum insulin secretion capacity in women with early-onset and late-onset gestational diabetes.
Journal: BMJ open diabetes research & care
Published: March 26, 2025
Role of galectin-9 in the development of gestational diabetes mellitus.
Journal: Scientific reports
Published: February 17, 2025
Case of type 1 diabetes mellitus with decreased hemoglobin glycation index after switching insulin pump.
Journal: Journal of diabetes investigation
Published: January 20, 2025
Maturity-Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report.
Journal: Clinical case reports
Published: September 09, 2024
HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors.
Journal: Frontiers in endocrinology
Published: May 28, 2024
Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).
Journal: BMJ open diabetes research & care
Published: March 31, 2024
Last Updated: 09/26/2026